$283 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 9 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | KARUNA THERAPEUTICS INC | $104,312,000 | +7.3% | 852,708 | 0.0% | 36.87% | -3.8% | |
| New | RALLYBIO CORP | $39,930,000 | – | 2,271,311 | +100.0% | 14.11% | – | |
| PCVX | VAXCYTE INC | $35,656,000 | +12.7% | 1,405,421 | 0.0% | 12.60% | +1.1% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $23,927,000 | -18.2% | 1,891,467 | 0.0% | 8.46% | -26.6% | |
| AKUS | AKOUOS INC | $20,829,000 | -7.5% | 1,794,088 | 0.0% | 7.36% | -17.0% | |
| INZY | INOZYME PHARMA INC | $18,441,000 | -32.0% | 1,591,154 | 0.0% | 6.52% | -39.0% | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $13,594,000 | -12.5% | 569,041 | 0.0% | 4.80% | -21.5% | |
| ALGS | ALIGOS THERAPEUTICS INC | $13,595,000 | -23.9% | 876,548 | 0.0% | 4.80% | -31.8% | |
| FUSN | Buy | FUSION PHARMACEUTICALS INC | $12,659,000 | +0.4% | 1,598,379 | +0.0% | 4.47% | -10.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 12 | Q3 2023 | 65.4% |
| VAXCYTE INC | 12 | Q3 2023 | 19.5% |
| INOZYME PHARMA INC | 12 | Q3 2023 | 10.8% |
| ARCUTIS BIOTHERAPEUTICS INC | 12 | Q3 2023 | 6.2% |
| FUSION PHARMACEUTICALS INC | 12 | Q3 2023 | 6.2% |
| ALIGOS THERAPEUTICS INC | 12 | Q3 2023 | 8.0% |
| BOLT BIOTHERAPEUTICS INC | 11 | Q3 2023 | 20.0% |
| RALLYBIO CORP | 9 | Q3 2023 | 14.1% |
| AKOUOS INC | 8 | Q3 2022 | 11.7% |
| EXSCIENTIA PLC | 8 | Q3 2023 | 6.4% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.